IV 

110TH CONGRESS 

1ST SESSION H. CON. RES. 182 

Recognizing the need to pursue research into the causes, a treatment, and 

an eventual cure for idiopathic pulmonary fibrosis, supporting the goals 

and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JULY 12, 2007 

Mr. DEAL of Georgia (for himself, Mr. BAIRD, Mr. CASTLE, Mr. UPTON, Mr. 

WESTMORELAND, Mr. GINGREY, and Mr. MILLER of North Carolina) 

submitted the following concurrent resolution; which was referred to the 

Committee on Energy and Commerce 

CONCURRENT RESOLUTION 

Recognizing the need to pursue research into the causes, 

a treatment, and an eventual cure for idiopathic pulmonary fibrosis, supporting the goals and ideals of National Idiopathic Pulmonary Fibrosis Awareness Week, 

and for other purposes. 

Whereas idiopathic pulmonary fibrosis is a serious lung disorder causing progressive, incurable lung scarring; 

Whereas idiopathic pulmonary fibrosis is one of about 200 

disorders called interstitial lung diseases; 

Whereas idiopathic pulmonary fibrosis is the most common 

form of interstitial lung disease; 


ccoleman on PROD1PC69 with BILLS
2 

•HCON 182 IH 

Whereas idiopathic pulmonary fibrosis is a debilitating and 

generally fatal disease marked by progressive scarring of 

the lungs, causing an irreversible loss of the lung tissue’s 

ability to transport oxygen; 

Whereas idiopathic pulmonary fibrosis progresses quickly, 

often causing disability or death within a few short years; 

Whereas there is no proven cause of idiopathic pulmonary fibrosis; 

Whereas more than 128,000 United States citizens have idiopathic pulmonary fibrosis, and more than 48,000 new 

cases are diagnosed each year representing a 156-percent 

increase in mortality since 2001; 

Whereas idiopathic pulmonary fibrosis is often misdiagnosed 

or under diagnosed; 

Whereas the median survival rate for idiopathic pulmonary fibrosis patients is 2 to 3 years; about two-thirds of idiopathic pulmonary fibrosis patients die within 5 years; and 

approximately 40,000 patients die each year; and 

Whereas a need has been identified to increase awareness and 

detection of this misdiagnosed and under diagnosed disorder as well as all incarnations of pulmonary fibrosis: 

Now, therefore, be it 

1 Resolved by the House of Representatives (the Senate 

2 concurring), That the Congress— 

3 (1) recognizes the need to pursue research into 

4 the causes, a treatment, and an eventual cure for id5 iopathic pulmonary fibrosis; 

6 (2) supports the work of advocates and organi7 zations in educating, supporting, and providing hope 


ccoleman on PROD1PC69 with BILLS
3 

•HCON 182 IH 

1 for individuals who suffer from idiopathic pulmonary 

2 fibrosis, including efforts to organize a National Idi3 opathic Pulmonary Fibrosis Awareness Week; 

4 (3) supports the designation of an appropriate 

5 week as National Idiopathic Pulmonary Fibrosis 

6 Awareness Week; 

7 (4) welcomes the issuance of a proclamation 

8 designating a National Idiopathic Pulmonary Fibro9 sis Awareness Week; 

10 (5) congratulates advocates and organizations 

11 for their efforts to educate the public about idio12 pathic pulmonary fibrosis, while funding research to 

13 help find a cure for this disorder; and 

14 (6) supports the goals and ideals of National 

15 Idiopathic Pulmonary Fibrosis Awareness Week. 

Æ 


ccoleman on PROD1PC69 with BILLS